Strides Shasun Shares receives Inspection report

Inspection report from US health regulator has been recived by Strides Shasun. The inspection was done for its formulations facility at Bengaluru.

“The company’s formulations facility (KRSG Gardens) in Bengaluru, which was inspected by the USFDA in May 2017, has received the EIR, thereby confirming the closure of the inspection,” Strides said in a BSE filing today.

Many present and upcoming products of US are supported by The KRSG Gardens facility. It manufactures tablets, capsules, liquids, sachets, creams and ointments.

Strides Shasun Shares were trading at Rs 927.50 apiece, up 2.10 per cent from the previous close on the BSE.